Search

Author/Creator Rodoman, Grigory

2. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022)

Authors:
Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian; Abdulkhakov, Rustem; Abu ...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 1(2022)
Page Start:
17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals. Issue 9 (7th June 2021)

Authors:
Melikhov, Oleg; Kruglova, Tatiana; Lytkina, Karine; Melkonyan, Georgy; Prokhorovich, Elena; Putsman, Gleb; Rodoman, Grigory; Vertkin, Arkady; Zagrebneva, Alena; Stebbing, Justin
Journal:
Annals of the rheumatic diseases
Issue:
Volume 80:Issue 9(2021)
Page Start:
1245
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗